Travere: 4Q Earnings Snapshot

SAN DIEGO (AP) _ Travere Therapeutics, Inc. (TVTX) on Monday reported a loss of $121.6 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of $2.37.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.

The drug developer posted revenue of $51 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $51.3 million.

For the year, the company reported that its loss widened to $169.4 million, or $3.56 per share. Revenue was reported as $198.3 million.

Travere shares have climbed 12% since the beginning of the year. In the final minutes of trading on Monday, shares hit $30.56, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVTX at https://www.zacks.com/ap/TVTX